FRM
CRL icon

Fox Run Management’s Charles River Laboratories CRL Stock Holding History

Fox Run Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,637
Closed -$400K – 979
2025
Q2 		$400K Buy
+2,637
New +$352K 0.07% 548
2023
Q2 		– Sell
-4,320
Closed -$872K – 743
2023
Q1 		$872K Buy
+4,320
New +$979K 0.28% 90
2022
Q3 		– Sell
-2,549
Closed -$545K – 641
2022
Q2 		$545K Buy
+2,549
New +$623K 0.27% 101
2020
Q3 		– Sell
-1,154
Closed -$201K – 198
2020
Q2 		$201K Buy
+1,154
New +$184K 0.27% 215
2019
Q1 		– Sell
-7,116
Closed -$805K – 502
2018
Q4 		$805K Buy
+7,116
New +$891K 0.43% 20
2018
Q2 		– Sell
-6,660
Closed -$711K – 707
2018
Q1 		$711K Buy
+6,660
New +$718K 0.17% 190
2017
Q4 		– Sell
-4,400
Closed -$475K – 702
2017
Q3 		$475K Buy
+4,400
New +$452K 0.13% 311
2017
Q2 		– Sell
-7,400
Closed -$666K – 664
2017
Q1 		$666K Sell
7,400
-2,700
-27% -$229K 0.27% 97
2016
Q4 		$770K Buy
10,100
+1,200
+13% +$91.1K 0.4% 26
2016
Q3 		$742K Sell
8,900
-300
-3% -$25.1K 0.44% 20
2016
Q2 		$758K Buy
+9,200
New +$758K 0.37% 30

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fox Run Management's CRL Position: Q3 2025 in Review

Fox Run Management sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 2,637 shares — an estimated $400K sold.

Fox Run Management first reported a position in CRL in Q2 2016 and held it in 11 quarters. The position peaked at $872K in Q1 2023. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Fox Run Management reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Fox Run Management sold 2,637 Charles River Laboratories shares in Q3 2025, an estimated $400K.
  • Fox Run Management first reported a position in Charles River Laboratories in Q2 2016 and held it in 11 quarters.
  • Fox Run Management's Charles River Laboratories position peaked at $872K in Q1 2023.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.